Altimmune (NASDAQ: ALT), a clinical-stage biopharmaceutical company, has completed an underwritten public offering resulting in gross proceeds for the company of an estimated $132.2 million. According to a recent announcement, the company closed the offering of 4,119,564 shares of its common stock, including 750,000 additional shares pursuant to the full exercise of the over-allotment option granted to underwriters and other specific investors, prefunded warrants to purchase 1,630,436 shares of ALT common stock at an exercise price of $0.0001 per share. The public offering price of each share was $23, while the public offering price of each prefunded warrant was $22.999 per underlying share, resulting in the gross proceeds. ROTH Capital Partners acted as co-manager for the offering.
To view the full press release, visit http://nnw.fm/cGS5z
Altimmune is a clinical-stage biopharmaceutical company focused on developing treatments for liver disease, immune modulating therapies and intranasal vaccines. Altimmune’s diverse pipeline of product candidates includes next-generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell(TM)), an intranasal immune-modulating treatment for COVID-19 (T-COVID(TM)) and intranasal vaccines (AdCOVID(TM), NasoShield(TM) and NasoVAX(TM)). For more information, visit the company’s website at www.Altimmune.com.
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork